Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis
Hong Zou,1,2 Li Li,1 Ines Garcia Carcedo,1 Zhi Ping Xu,1 Michael Monteiro,1 Wenyi Gu1 1Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Brisbane, QLD, Australia; 2Department of Pathology, Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shi...
Guardado en:
Autores principales: | Zou H, Li L, Garcia Carcedo I, Xu ZP, Monteiro M, Gu WY |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97c1c0907c4440d1bb6c861ea9ae6a5c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis
por: Hu Y, et al.
Publicado: (2021) -
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Eun Jin Sun, et al.
Publicado: (2021) -
PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells
por: Shreya Udawant, et al.
Publicado: (2021) -
Function of selected natural antidiabetic compounds with potential against cancer via modulation of the PI3K/AKT/mTOR cascade
por: Agustina Dwi Retno Nurcahyanti, et al.
Publicado: (2021) -
Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells
por: Liu,Xiaoli, et al.
Publicado: (2019)